Fortress Biotech Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2008
Net Income	-68.67	-94.61	-64.7	-46.53	-39.96	-84.15	-66.88	-55.1	-48.43	-20.39	Upgrade
Depreciation & Amortization	8.08	9.35	4.32	3.91	3.48	1.39	0.73	0.94	0.03	0.02	Upgrade
Share-Based Compensation	17.03	22.99	19.49	13.45	13.19	15.01	13.4	12.13	14.29	5.55	Upgrade
Other Operating Activities	-92.69	-125.17	-75.64	-54.51	-71.67	-31.11	-28.56	-3.79	13.73	-1.52	Upgrade
Operating Cash Flow	-128.23	-179.4	-116.54	-83.68	-94.96	-98.85	-81.31	-45.81	-20.38	-16.33	Upgrade
Capital Expenditures	5.94	-2.59	-4.97	-3.13	-4.75	-7.08	-0.65	-6.37	-0.28	0	Upgrade
Acquisitions	0	-20	56.86	0	-1.2	-1.2	0	4.45	-0.16	0	Upgrade
Change in Investments	0	0	0	0	17.6	18.4	-36	0	20	-23.27	Upgrade
Other Investing Activities	-8.04	-0.34	-11.38	-4.04	8.44	8.71	-3.57	-4.14	-11.68	-	Upgrade
Investing Cash Flow	-2.1	-22.93	40.51	-7.16	20.1	18.82	-40.22	-6.06	7.89	-23.27	Upgrade
Share Issuance / Repurchase	24.12	4.53	9.36	46.03	20.38	7.22	0.22	0.62	0.28	4.12	Upgrade
Debt Issued / Paid	-39	48.65	-9.73	-34.12	13.36	15.03	36.98	6.14	10	0.36	Upgrade
Other Financing Activities	47.62	22.14	149.36	160.5	112.98	28.41	113.19	36.15	50.64	-14.63	Upgrade
Financing Cash Flow	32.74	75.32	148.99	172.41	146.71	50.65	150.38	42.91	60.92	-10.16	Upgrade
Net Cash Flow	-97.59	-127.01	72.97	81.56	71.85	-29.38	28.85	-8.97	48.42	-49.76	Upgrade
Free Cash Flow	-122.29	-181.99	-121.51	-86.81	-99.71	-105.93	-81.95	-52.18	-20.66	-16.33	Upgrade
Free Cash Flow Margin	-144.70%	-240.27%	-176.63%	-190.37%	-272.21%	-394.06%	-475.23%	-316.64%	-2394.09%	-	Upgrade
Free Cash Flow Per Share	-15.08	-30.72	-22.31	-18.08	-27.34	-36.56	-29.51	-19.59	-7.92	-6.75	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).